Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...
Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...
Robert F. Kennedy's nomination will put Republican lawmakers' loyalty to the test, as the former Democrat holds a range of ...
WEST JEFFERSON, OHIO / ACCESS Newswire / January 30, 2025 / AmplifyBio, a leading preclinical CRO and CDMO played a pivotal ...
Tubulis announced today that its second drug candidate, TUB-030, has entered clinical evaluation with successful dosing of the first patient in the 5-STAR 1-01 Phase I/IIa trial (NCT06657222). The ...
Lubbock saw its first case of measles after 21 years, prompting health officials to advocate for the vaccine and safety. Here ...
Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...
In the years 1880 to 1920, we literally transformed the health environment,” says David Rosner, a professor of history and public health at Columbia University, and author of the book, Building the ...
India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.
Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...
Researchers have found a new way to reduce the effects of pre-eclampsia using mRNA-lipid nanoparticle therapies.
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...